Brief: Organovo Announces Fxr Program

VivoSim Labs

21/03/2023 12:42

March 21 (Reuters) - Organovo Holdings Inc  ONVO.O :
    * ORGANOVO ANNOUNCES FXR PROGRAM
    * ORGANOVO HOLDINGS INC - ANNOUNCED A CLINICAL PROGRAM FOR
FXR
314, AN FXR AGONIST THAT HAS COMPLETED INITIAL CLINICAL TRIALS
    * ORGANOVO HOLDINGS INC - CONTINUES TO EXPECT TO FILE INDS
STARTING IN 2025 FROM FULLY INTERNALLY DEVELOPED MOLECULES

Source text for Eikon:  ID:nGNX9PJf3j 
Further company coverage:  ONVO.O 

 ((Reuters.Briefs@thomsonreuters.com;;))